EUVIMEDEUVIMED entdecken
Crossref

Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza

Yongli Gu, Daoli Jiang

Int. Journal of Clinical Pharmacology and Therapeutics · 25.09.2026

DOI: 10.5414/cp204995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 25.09.2026. Verfasst von Yongli Gu und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gu, Y., & Jiang, D. (2026). Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204995

Vancouver

Gu Y, Jiang D. Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp204995

BibTeX
@article{Gu2026,
  author = {Gu, Yongli and Jiang, Daoli},
  title = {Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.5414/cp204995}
}
Kostenlos starten →